Jang Ik Lee

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications
    Jang Ik Lee
    Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Clin Pharmacokinet 49:295-310. 2010
  2. ncbi New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
    Shiew Mei Huang
    Office of Clinical Pharmacology, CDER, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
    J Clin Pharmacol 48:662-70. 2008

Collaborators

Detail Information

Publications2

  1. ncbi CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications
    Jang Ik Lee
    Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Clin Pharmacokinet 49:295-310. 2010
    ..The authors of this review suggest that effort be made to understand TP-drug interactions for the safe and effective use of TPs in combination with small-molecule drugs...
  2. ncbi New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
    Shiew Mei Huang
    Office of Clinical Pharmacology, CDER, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
    J Clin Pharmacol 48:662-70. 2008
    ....